Mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) are being utilized for the development of multitude of regenerative therapies. Establishing standards and practices for characterizing MSCs and iPSCs is an important quality issue for the future of stem cell research and regenerative medicine. Simple steps can be taken to improve the quality and efficiency of both MSC and iPSC expansion and differentiation.
